Terns Pharmaceuticals Stock Price Prediction
| TERN Stock | USD 4.06 0.02 0.49% |
Momentum 37
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.32) | EPS Estimate Current Year (1.19) | EPS Estimate Next Year (1.32) | Wall Street Target Price 19.0625 |
Using Terns Pharmaceuticals hype-based prediction, you can estimate the value of Terns Pharmaceuticals from the perspective of Terns Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Terns Pharmaceuticals using Terns Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Terns using crowd psychology based on the activity and movement of Terns Pharmaceuticals' stock price.
Terns Pharmaceuticals Implied Volatility | 2.58 |
Terns Pharmaceuticals' implied volatility exposes the market's sentiment of Terns Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Terns Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Terns Pharmaceuticals stock will not fluctuate a lot when Terns Pharmaceuticals' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Terns Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Terns because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Terns Pharmaceuticals after-hype prediction price | USD 4.07 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Terns contract
Based on the Rule 16, the options market is currently suggesting that Terns Pharmaceuticals will have an average daily up or down price movement of about 0.16% per day over the life of the 2025-04-17 option contract. With Terns Pharmaceuticals trading at USD 4.06, that is roughly USD 0.006547 . If you think that the market is fully incorporating Terns Pharmaceuticals' daily price movement you should consider acquiring Terns Pharmaceuticals options at the current volatility level of 2.58%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Terns |
Terns Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Terns Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Terns Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Terns Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Terns Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Terns Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Terns Pharmaceuticals' historical news coverage. Terns Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.20 and 8.39, respectively. We have considered Terns Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Terns Pharmaceuticals is slightly risky at this time. Analysis and calculation of next after-hype price of Terns Pharmaceuticals is based on 3 months time horizon.
Terns Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Terns Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Terns Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Terns Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.46 | 4.32 | 0.01 | 0.02 | 7 Events / Month | 6 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
4.06 | 4.07 | 0.25 |
|
Terns Pharmaceuticals Hype Timeline
Terns Pharmaceuticals is at this time traded for 4.06. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of -0.02. Terns is projected to increase in value after the next headline, with the price projected to jump to 4.07 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 0.25%, whereas the daily expected return is at this time at -0.46%. The volatility of related hype on Terns Pharmaceuticals is about 8640.0%, with the expected price after the next announcement by competition of 4.04. Net Loss for the year was (90.21 M) with profit before overhead, payroll, taxes, and interest of 1000 K. Given the investment horizon of 90 days the next projected press release will be in about 7 days. Check out Terns Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Terns Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Terns Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Terns Pharmaceuticals' future price movements. Getting to know how Terns Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Terns Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AMLX | Amylyx Pharmaceuticals | 0.01 | 8 per month | 0.00 | (0.17) | 6.14 | (9.09) | 20.49 | |
| ABOS | Acumen Pharmaceuticals | 0.05 | 7 per month | 0.00 | (0.26) | 6.70 | (7.10) | 16.77 | |
| INZY | Inozyme Pharma | 0.02 | 5 per month | 0.00 | (0.23) | 7.72 | (8.75) | 38.13 | |
| XFOR | X4 Pharmaceuticals | (0.15) | 9 per month | 11.18 | 0.05 | 32.50 | (14.29) | 68.45 | |
| MREO | Mereo BioPharma Group | (0.04) | 7 per month | 0.00 | (0.13) | 6.16 | (7.59) | 20.77 | |
| PDSB | PDS Biotechnology Corp | (0.15) | 7 per month | 0.00 | (0.16) | 8.50 | (10.12) | 22.87 | |
| HOOK | Hookipa Pharma | 0.03 | 8 per month | 0.00 | (0.17) | 6.90 | (7.88) | 32.80 | |
| DAWN | Day One Biopharmaceuticals | (0.27) | 7 per month | 0.00 | (0.17) | 3.92 | (3.68) | 10.17 | |
| ELDN | Eledon Pharmaceuticals | 0.05 | 6 per month | 0.00 | (0) | 8.92 | (6.22) | 18.63 |
Terns Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Terns price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Terns using various technical indicators. When you analyze Terns charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Terns Pharmaceuticals Predictive Indicators
The successful prediction of Terns Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Terns Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Terns Pharmaceuticals based on analysis of Terns Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Terns Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Terns Pharmaceuticals's related companies. | 2022 | 2023 | 2024 | 2025 (projected) | PB Ratio | 1.32 | 1.81 | 2.08 | 1.98 | Capex To Depreciation | 0.27 | 0.059 | 0.0679 | 0.0645 |
Story Coverage note for Terns Pharmaceuticals
The number of cover stories for Terns Pharmaceuticals depends on current market conditions and Terns Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Terns Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Terns Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Terns Pharmaceuticals Short Properties
Terns Pharmaceuticals' future price predictability will typically decrease when Terns Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Terns Pharmaceuticals often depends not only on the future outlook of the potential Terns Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Terns Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 71.3 M | |
| Cash And Short Term Investments | 263.4 M |
Check out Terns Pharmaceuticals Basic Forecasting Models to cross-verify your projections. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Terns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Terns Pharmaceuticals is measured differently than its book value, which is the value of Terns that is recorded on the company's balance sheet. Investors also form their own opinion of Terns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Terns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Terns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Terns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Terns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.